Q/C TECHNOLOGIES, INC. — Director's Dealing 2017

Feb 13, 2017

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Akers Biosciences Inc (AKER)
CIK: 0001321834
Period of Report: 2016-12-31

Reporting Person: KNOX BRANDON THOMAS (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-09-02	Common Stock	G	13750	—	Disposed	124326	Direct

Footnotes

F1: Such shares were a bona fide gift. No consideration was received.